Introduction of new technologies and their applications to neuroblastoma diagnosis, treatment, and therapy assessment are explained. Role of molecular ghenetics in diagnosis and therapy for neuroblastoma patients is detailed. Molecular detection of minimal residual neuroblastoma is described. Magnet
โฆ LIBER โฆ
Molecular Diagnosis of Cancer Volume 0 || Quantitative Analysis of PRAME for Detection of Minimal Residual Disease in Leukemia
โ Scribed by Roulston, Joseph E.; Bartlett, John M. S.
- Book ID
- 121458199
- Publisher
- Humana Press
- Year
- 2004
- Weight
- 197 KB
- Category
- Article
- ISBN-13
- 9781592597604
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
[Pediatric Cancer] Neuroblastoma Volume
โ
Hayat, M.A.
๐
Article
๐
2011
๐
Springer Netherlands
๐
Dutch
โ 301 KB
Molecular diagnosis of minimal residual
โ
A. Peggy Graveland, Boudewijn J. M. Braakhuis, Simone E. J. Eerenstein, Remco de
๐
Article
๐
2012
๐
Springer Netherlands
๐
English
โ 453 KB
New approaches for the detection of mini
โ
Anna van Rhenen; Bijan Moshaver; Gert J. Ossenkoppele; Gerrit Jan Schuurhuis
๐
Article
๐
2007
๐
Current Science Inc.
๐
English
โ 855 KB
991 PUBLICATION Quantitative analysis of
๐
Article
๐
2005
๐
Elsevier Science
๐
English
โ 144 KB
Expression patterns of WT1 and PRAME in
โ
YaZhen Qin; HongHu Zhu; Bin Jiang; JinLan Li; XiJing Lu; LingDi Li; GuoRui Ruan;
๐
Article
๐
2009
๐
Elsevier Science
๐
English
โ 198 KB
Both WT1 and PRAME are highly expressed in acute myeloid leukemia (AML) patients. To assess the efficacy of their simultaneous detection for the purpose of monitoring minimal residual disease (MRD), we used real-time quantitative RT-PCR to quantify both WT1 and PRAME transcript levels in the bone ma
Deep-sequencing approach for minimal res
โ
Faham, M.; Zheng, J.; Moorhead, M.; Carlton, V. E. H.; Stow, P.; Coustan-Smith,
๐
Article
๐
2012
๐
American Society of Hematology
๐
English
โ 92 KB